Compugen reported 5.58 in PE Price to Earnings for its fiscal quarter ending in June of 2026.





Pe Change Date
Brainstorm Cell Therapeutics 0.03 5.89 Sep/2025
Cara Therapeutics 0.49 27.28 Mar/2026
Clal Biotechnology 11.67 2.62 Dec/2022
Compugen 5.58 0.12 Jun/2026
RedHill Biopharma 0.04 0.03 Jun/2025
TherapeuticsMD 0.75 3.3 Mar/2023